Basilea Pharmaceutica Ltd
Prof. Achim Kaufhold, German citizen, has served as Chief Medical Officer since February 2010. He holds a medical degree from the University of Cologne (Germany). During his 10-year academic career he worked in the fields of pediatrics, basic and applied medical microbiology, laboratory medicine and infectious diseases in Germany and the U.S. He is Professor of Medical Microbiology and Infectious Diseases and member of the Faculty of Medicine of the University of Aachen (Germany), and also served as a member of the board of directors of Vaximm AG (until February 2016). He has spent more than 20 years in senior management positions in the biotech and pharmaceutical industry, mainly in leadership roles in research, product and business development, and general management. Prior to joining Basilea, from 2008 to 2009, he served as the President and Chief Executive Officer of Affitech A/S. From 2007 to 2008, Prof. Kaufhold worked at Pharmexa A/S, first as its Chief Medical Officer and Chief Scientific Officer before becoming Chief Executive Officer. From 2005 to 2006, Prof. Kaufhold served as the Chief Medical Officer and Vice President of Development at Chiron. From 2001 to 2005, he served as the Chief Medical Officer of Berna Biotech AG, and as its Head of Research, Product and Business Development. From 1994 to 2001 he served as Director of Clinical Development and Head of the Pediatric Vaccines Development Unit of GlaxoSmithKline Biologicals.
Microbiology, Cell Biology